Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
4-Fluoro-2-methoxy-3-nitro-benzenamine is an impurity from the synthesis of Osimertinib (A808075), a selective EGFR inhibitor (epidermal growth factor receptor) used in the treatments of nonsmall-cell lung cancer.